Chris Aiken, MD, Author at PsychPartners - Page 2 of 14

Stimulant Misuse Is Declining

ADHD Child Psychiatry Cocaine Medications Research Stimulants Substance Use

Stimulant Misuse Is Declining

June 9, 2026by Chris Aiken, MD0

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

Alcohol Medications Research Substance Use

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

June 9, 2026by Chris Aiken, MD0

Light Therapy Added to CBT Reduces Daytime Sleepiness

Lifestyle Light Therapy Research Sleep Therapy

Light Therapy Added to CBT Reduces Daytime Sleepiness

June 9, 2026by Chris Aiken, MD0

Laughter Therapy for Depression and Anxiety

Anxiety Depression Research Research for the Public Therapy

Laughter Therapy for Depression and Anxiety

June 9, 2026by Chris Aiken, MD0

Ondansetron in OCD

Medications OCD Research

Ondansetron in OCD

June 9, 2026by Chris Aiken, MD1

Antidepressants in Pregnancy and Neurodevelopmental Risks

ADHD Antidepressants Autism Depression Disorders Medications Research Research for the Public Women's Health

Antidepressants in Pregnancy and Neurodevelopmental Risks

June 9, 2026by Chris Aiken, MD2

Medications for Borderline Personality Disorder: A Ranking

Disorders Medications Personality Disorders Research

Medications for Borderline Personality Disorder: A Ranking

June 9, 2026by Chris Aiken, MD0

Buspirone Augments Clozapine in Schizophrenia

Antipsychotics Clozapine Cognition Medications Research Schizophrenia and Psychosis Top Research

Buspirone Augments Clozapine in Schizophrenia

June 9, 2026by Chris Aiken, MD0

Ultraprocessed Foods Linked to Dementia

Cognition Dementia Geriatric Psychiatry Lifestyle Nutrition Research Research for the Public

Ultraprocessed Foods Linked to Dementia

June 8, 2026by Chris Aiken, MD0

Ketamine in Teens with Suicidality

Child Psychiatry Depression Difficult to Treat Depression Ketamine Research

Ketamine in Teens with Suicidality

June 8, 2026by Chris Aiken, MD0

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

Addiction Meds Cocaine Medications Methamphetamine Research Substance Use Top Research

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

June 8, 2026by Chris Aiken, MD0

Start Lithium Earlier for Shorter Hospital Stays

Bipolar Bipolar Meds Lithium Medications Research Top Research

Start Lithium Earlier for Shorter Hospital Stays

June 8, 2026by Chris Aiken, MD0

A Lithium GLP-1 Interaction

Bipolar Bipolar Meds GLP1 Agonists Lithium Research Side Effects

A Lithium GLP-1 Interaction

June 8, 2026by Chris Aiken, MD0

FDA Clears a New Type of TMS for PTSD

Devices Disorders Neuromodulation/TMS PTSD Research Research for the Public Top Research

FDA Clears a New Type of TMS for PTSD

June 7, 2026by Chris Aiken, MD0

Olanzapine May Raise Liver Enzymes

Antipsychotics Bipolar Meds Medications Research Side Effects

Olanzapine May Raise Liver Enzymes

June 3, 2026by Chris Aiken, MD0

TMS for Anorexia and Bulimia

Disorders Eating Disorders Neuromodulation/TMS Research

TMS for Anorexia and Bulimia

June 2, 2026by Chris Aiken, MD0

FDA Moves the Goalposts on Alcohol Treatment

Addiction Meds Alcohol Research Substance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0

Melatonin Protects Memory During ECT

Bipolar Depression Difficult to Treat Depression ECT Research Sleep Supplements

Melatonin Protects Memory During ECT

June 2, 2026by Chris Aiken, MD2

Smartphones in Borderline Personality Disorder: Friend and Foe

Disorders Lifestyle Personality Disorders Research Research for the Public Therapy

Smartphones in Borderline Personality Disorder: Friend and Foe

June 1, 2026by Chris Aiken, MD0

Risk Factors for Gambling on Pramipexole

Bipolar Depression Difficult to Treat Depression Disorders Medications Research Side Effects

Risk Factors for Gambling on Pramipexole

June 1, 2026by Chris Aiken, MD0